Finance
Results: 11617-11628 of 41796

Polpharma Biologics and MS Pharma Sign Licensing Agreements for Proposed Vedolizumab (PB016), Ocrelizumab (PB018) and Guselkumab (PB019) Biosimilars

Saving energy, costs and downtime: HIKMICRO sets new predictive maintenance standards for the toughest manufacturing industries

Jungbunzlauer to acquire from International Flavors & Fragrances, Inc. multipurpose site in Thomson, IL




